Article

Substrate selectivity and pH dependence of KAAT1 expressed in Xenopus laevis oocytes.

Istituto di Fisiologia Generale e di Chimica Biologica, Facoltà di Farmacia, Università di Milano, Via Trentacoste 2, 20134 Milano, Italy.
Journal of Membrane Biology (Impact Factor: 2.48). 05/2000; 174(3):213-24. DOI: 10.1007/s002320001046
Source: PubMed

ABSTRACT When expressed in Xenopus oocytes KAAT1 increases tenfold the transport of l-leucine. Substitution of NaCl with 100 mm LiCl, RbCl or KCl allows a reduced but significant activation of l-leucine uptakes. Chloride-dependence is not strict since other pseudohalide anions such as thyocyanate are accepted. KAAT1 is highly sensitive to pH. It can transport l-leucine at pH 5.5 and 8, but the maximum uptake has been observed at pH 10, near to the physiological pH value, when amino and carboxylic groups are both deprotonated. The pH value mainly influences the V(max) in Na(+) activation curves and l-leucine kinetics. The kinetic parameters are K(mNa) = 4.6 +/- 2 mm, V(maxNa) = 14.8 +/- 1.7 pmol/oocyte/5 min for pH 8.0 and K(mNa) = 2. 8 +/- 0.7 mm, V(maxNa) = 31.3 +/- 1.9 pmol/oocyte/5 min for pH 10.0. The kinetic parameters of l-leucine uptake are: K(m) = 120.4 +/- 24. 2 microm, V(max) = 23.2 +/- 1.4 pmol/oocyte/5 min at pH 8.0 and K(m) = 81.3 +/- 24.2 microm, V(max) = 65.6 +/- 3.9 pmol/oocyte/5 min at pH 10.0. On the basis of inhibition experiments, the structural features required for KAAT1 substrates are: (i) a carboxylic group, (ii) an unsubstituted alpha-amino group, (iii) the side chain is unnecessary, if present it should be uncharged regardless of length and ramification.

0 Bookmarks
 · 
57 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: KAAT1 is a neutral amino acid transporter activated by K+ or by Na+ (9). The protein shows significant homology with members of the Na+/Cl--dependent neurotransmitter transporter super family. E59G KAAT1, expressed in Xenopus oocytes, exhibited a reduced leucine uptake [20-30% of wild-type (WT)], and kinetic analysis indicated that the loss of activity was due to reduction of Vmax and apparent affinity for substrates. Electrophysiological analysis revealed that E59G KAAT1 has presteady-state and uncoupled currents larger than WT but no leucine-induced currents. Site-directed mutagenesis analysis showed the requirement of a negative charge in position 59 of KAAT1. The analysis of permeant and impermeant methanethiosulfonate reagent effects confirmed the intracellular localization of glutamate 59. Because the 2-aminoethyl methanethiosulfonate hydrobromid inhibition was not prevented by the presence of Na+ or leucine, we concluded that E59 is not directly involved in the binding of substrates. N-ethylmaleimide inhibition was qualitatively and quantitatively different in the two transporters, WT and E59G KAAT1, having the same cysteine residues. This indicates an altered accessibility of native cysteine residues due to a modified spatial organization of E59G KAAT1. The arginine modifier phenylglyoxal effect supports this hypothesis: not only cysteine but also arginine residues become more accessible to the modifying reagents in the mutant E59G. In conclusion, the results presented indicate that glutamate 59 plays a critical role in the three-dimensional organization of KAAT1.
    AJP Cell Physiology 10/2003; 285(3):C623-32. · 3.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phenylglyoxal (PGO), an arginine-modifying reagent, is an irreversible inhibitor of KAAT1-mediated leucine transport, expressed in Xenopus oocytes. The PGO effect was dose-dependent and 5 mm PGO determined a V(max) reduction to 24% of the control, consistent with the covalent binding to transporter arginine residues not located in the leucine binding site. The use of labelled [(14)C]PGO confirmed that the inhibitor binds KAAT1. The protein membrane domain contains seven arginine residues one of which, arginine 76, is conserved in the family of GABA transporters. Using site-directed mutagenesis we showed that only arginine 76 is crucial for KAAT1 activity and is involved in PGO binding.
    Insect Molecular Biology 09/2002; 11(4):283-9. · 3.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review focuses on the comparative physiology and phylogeny of plasma membrane transporters that absorb and redistribute amino acids in organisms. The first section briefly summarizes the life history of the environmental flux and metabolism of amino acids. It reveals a set of geological and biological events that may have shaped amino acid transport mechanisms, which evolved under everlasting antagonism of environmental availability, endogenous synthesis, and metabolic consumption of proteinogenic amino acids. The second section addresses the phylogenetic and physiological diversity of experimentally and theoretically defined amino acid transporters. It reveals a set of gene duplications, expansions, and extinctions in the phylogenetic tree of the amino acid transporters, which correlate with the rapid acquisitions of new transport phenotypes and assured remarkable adaptive plasticity of the amino acid transport network. Specific emphasis in this review is placed on the Excitatory Amino Acid Transporters and the Sodium Neurotransmitter symporter families (SLC1 and SLC6, respectively). The early evolution of these cation-coupled transporters compensating the anabolism of proteinogenic amino acids may have simultaneously driven the expansion of heterotrophy and the extinction of principal metabolic pathways (e.g. nitrogen fixation in prokaryotes and essential amino acid synthesis cascades in Metazoans). Furthermore, the extant physiological functions of these transporters – including the balance of dispensable and essential amino acids, cellular signaling, and neurochemical communication – are critical for the metabolic integrity and health of metazoan organisms. Molecular, genetic, and structural analyses of amino acid transporters have emphasized this point, and continue to provide us with an expanding knowledge base that will ultimately lead to new biomedical technologies for curing metabolic disorders and controlling pathogenic and pest organisms. KeywordsEssential-Amino acid-Transport-System-Metabolism-Evolution-SLC-TCDB
    03/2010: pages 379-472;